INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2930, 11153, 'Tamoxifen', 'Due to their estrogenic effect, isoflavones present in soy such as genistein and daidzein may stimulate breast tumor growth and antagonize the antiproliferative action of tamoxifen.', 'soybean', 'Moderate', '', 'DDInter', 0, X'789c558ed11183300c4357d1002d4b74860e608801df2576ce312d6cdfc047affdb3744f969e1a9251cc19a2b379a110534803bd48328d996fa8dd648d8670a6e084b7c48aa062bbccac287460326d92d87bce24892e3047962271deb1f2456ca55eff6d46b3e3dead20d193a86e699ba20dc0e31f5c9c7b47308134fd28dec3a9279036bf3abe7b7a9b533d40b532799f6d18198d661e3e993559dc', NULL, X'789c1d8ec10dc3300c0357e10045a7c822aa232702622990e4b4cdf4b5fbe4f10870e98c34e4cee2e048b78d550ab8562ef98084d5832e530e9ccec19a1045d817d1cb0e0acc41240f4aba622559ef191a0d25a5f58392f172a648646fe6d8dcdeb9ff75d2a4cd546e9e1f6694d3ed90ca4e29d72025c5145691d4ec330a7dfe0014194438');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2931, 11155, 'Tamoxifen', 'Due to their estrogenic effect, isoflavones present in soy such as genistein and daidzein may stimulate breast tumor growth and antagonize the antiproliferative action of tamoxifen.', 'soybean', 'Moderate', '', 'DDInter', 0, X'789c558ed11183300c4357d1002d4b74860e608801df2576ce312d6cdfc047affdb3744f969e1a9251cc19a2b379a110534803bd48328d996fa8dd648d8670a6e084b7c48aa062bbccac287460326d92d87bce24892e3047962271deb1f2456ca55eff6d46b3e3dead20d193a86e699ba20dc0e31f5c9c7b47308134fd28dec3a9279036bf3abe7b7a9b533d40b532799f6d18198d661e3e993559dc', NULL, X'789c1d8ec10dc3300c0357e10045a7c822aa232702622990e4b4cdf4b5fbe4f10870e98c34e4cee2e048b78d550ab8562ef98084d5832e530e9ccec19a1045d817d1cb0e0acc41240f4aba622559ef191a0d25a5f58392f172a648646fe6d8dcdeb9ff75d2a4cd546e9e1f6694d3ed90ca4e29d72025c5145691d4ec330a7dfe0014194438');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2932, 27883, 'Tamoxifen', 'Due to their estrogenic effect, isoflavones present in soy such as genistein and daidzein may stimulate breast tumor growth and antagonize the antiproliferative action of tamoxifen.', 'soybean', 'Moderate', '', 'DDInter', 0, X'789c558ed11183300c4357d1002d4b74860e608801df2576ce312d6cdfc047affdb3744f969e1a9251cc19a2b379a110534803bd48328d996fa8dd648d8670a6e084b7c48aa062bbccac287460326d92d87bce24892e3047962271deb1f2456ca55eff6d46b3e3dead20d193a86e699ba20dc0e31f5c9c7b47308134fd28dec3a9279036bf3abe7b7a9b533d40b532799f6d18198d661e3e993559dc', NULL, X'789c1d8ec10dc3300c0357e10045a7c822aa232702622990e4b4cdf4b5fbe4f10870e98c34e4cee2e048b78d550ab8562ef98084d5832e530e9ccec19a1045d817d1cb0e0acc41240f4aba622559ef191a0d25a5f58392f172a648646fe6d8dcdeb9ff75d2a4cd546e9e1f6694d3ed90ca4e29d72025c5145691d4ec330a7dfe0014194438');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2933, 27884, 'Tamoxifen', 'Due to their estrogenic effect, isoflavones present in soy such as genistein and daidzein may stimulate breast tumor growth and antagonize the antiproliferative action of tamoxifen.', 'soybean', 'Moderate', '', 'DDInter', 0, X'789c558ed11183300c4357d1002d4b74860e608801df2576ce312d6cdfc047affdb3744f969e1a9251cc19a2b379a110534803bd48328d996fa8dd648d8670a6e084b7c48aa062bbccac287460326d92d87bce24892e3047962271deb1f2456ca55eff6d46b3e3dead20d193a86e699ba20dc0e31f5c9c7b47308134fd28dec3a9279036bf3abe7b7a9b533d40b532799f6d18198d661e3e993559dc', NULL, X'789c1d8ec10dc3300c0357e10045a7c822aa232702622990e4b4cdf4b5fbe4f10870e98c34e4cee2e048b78d550ab8562ef98084d5832e530e9ccec19a1045d817d1cb0e0acc41240f4aba622559ef191a0d25a5f58392f172a648646fe6d8dcdeb9ff75d2a4cd546e9e1f6694d3ed90ca4e29d72025c5145691d4ec330a7dfe0014194438');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2934, 27885, 'Tamoxifen', 'Due to their estrogenic effect, isoflavones present in soy such as genistein and daidzein may stimulate breast tumor growth and antagonize the antiproliferative action of tamoxifen.', 'soybean', 'Moderate', '', 'DDInter', 0, X'789c558ed11183300c4357d1002d4b74860e608801df2576ce312d6cdfc047affdb3744f969e1a9251cc19a2b379a110534803bd48328d996fa8dd648d8670a6e084b7c48aa062bbccac287460326d92d87bce24892e3047962271deb1f2456ca55eff6d46b3e3dead20d193a86e699ba20dc0e31f5c9c7b47308134fd28dec3a9279036bf3abe7b7a9b533d40b532799f6d18198d661e3e993559dc', NULL, X'789c1d8ec10dc3300c0357e10045a7c822aa232702622990e4b4cdf4b5fbe4f10870e98c34e4cee2e048b78d550ab8562ef98084d5832e530e9ccec19a1045d817d1cb0e0acc41240f4aba622559ef191a0d25a5f58392f172a648646fe6d8dcdeb9ff75d2a4cd546e9e1f6694d3ed90ca4e29d72025c5145691d4ec330a7dfe0014194438');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2935, 4949, 'Sunitinib', 'Consumption of grapefruit or grapefruit juice during sunitinib therapy may increase the plasma concentrations of sunitinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c4d8e510ec3200c43afe2034cbb438f92420ad9805421a9d4db8ffeedd396fdecad79d52815a9c990440d999c40c66894be32ca0be2e874636750be64d2de18aea04b25c32b23e998d14f171dd06315adac6cd7183e1fa3189d7c582c90dabffa8424460e5b3b9831c4d789fd61aeccfdfe01c81b3a67', NULL, X'789c4d8f310ec2300c45afe20b5021510e807a0106164627755ba3c68eec64e8ed4990408cb6deffcf9e54bca65c58057481d530d362950ba8fd4fafca9160aec6b28257e1c2c201ca468d3920e1012cd1089dfa12f28e9e10a24a2429865de0ddf0cb0e008f0e9a66759a2151dc50d813b0b7ae8d037faf9a9ef7f17a86cb6d3c259a19cb072f1874ef7c382092156469be94b5caecad97bc995bd3df1bc31b25fd58e1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2936, 27741, 'Sunitinib', 'Consumption of grapefruit or grapefruit juice during sunitinib therapy may increase the plasma concentrations of sunitinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c4d8e510ec3200c43afe2034cbb438f92420ad9805421a9d4db8ffeedd396fdecad79d52815a9c990440d999c40c66894be32ca0be2e874636750be64d2de18aea04b25c32b23e998d14f171dd06315adac6cd7183e1fa3189d7c582c90dabffa8424460e5b3b9831c4d789fd61aeccfdfe01c81b3a67', NULL, X'789c4d8f310ec2300c45afe20b5021510e807a0106164627755ba3c68eec64e8ed4990408cb6deffcf9e54bca65c58057481d530d362950ba8fd4fafca9160aec6b28257e1c2c201ca468d3920e1012cd1089dfa12f28e9e10a24a2429865de0ddf0cb0e008f0e9a66759a2151dc50d813b0b7ae8d037faf9a9ef7f17a86cb6d3c259a19cb072f1874ef7c382092156469be94b5caecad97bc995bd3df1bc31b25fd58e1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2937, 27742, 'Sunitinib', 'Consumption of grapefruit or grapefruit juice during sunitinib therapy may increase the plasma concentrations of sunitinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c4d8e510ec3200c43afe2034cbb438f92420ad9805421a9d4db8ffeedd396fdecad79d52815a9c990440d999c40c66894be32ca0be2e874636750be64d2de18aea04b25c32b23e998d14f171dd06315adac6cd7183e1fa3189d7c582c90dabffa8424460e5b3b9831c4d789fd61aeccfdfe01c81b3a67', NULL, X'789c4d8f310ec2300c45afe20b5021510e807a0106164627755ba3c68eec64e8ed4990408cb6deffcf9e54bca65c58057481d530d362950ba8fd4fafca9160aec6b28257e1c2c201ca468d3920e1012cd1089dfa12f28e9e10a24a2429865de0ddf0cb0e008f0e9a66759a2151dc50d813b0b7ae8d037faf9a9ef7f17a86cb6d3c259a19cb072f1874ef7c382092156469be94b5caecad97bc995bd3df1bc31b25fd58e1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2938, 27743, 'Sunitinib', 'Consumption of grapefruit or grapefruit juice during sunitinib therapy may increase the plasma concentrations of sunitinib.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism by certain compounds present in grapefruit.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c4d8e510ec3200c43afe2034cbb438f92420ad9805421a9d4db8ffeedd396fdecad79d52815a9c990440d999c40c66894be32ca0be2e874636750be64d2de18aea04b25c32b23e998d14f171dd06315adac6cd7183e1fa3189d7c582c90dabffa8424460e5b3b9831c4d789fd61aeccfdfe01c81b3a67', NULL, X'789c4d8f310ec2300c45afe20b5021510e807a0106164627755ba3c68eec64e8ed4990408cb6deffcf9e54bca65c58057481d530d362950ba8fd4fafca9160aec6b28257e1c2c201ca468d3920e1012cd1089dfa12f28e9e10a24a2429865de0ddf0cb0e008f0e9a66759a2151dc50d813b0b7ae8d037faf9a9ef7f17a86cb6d3c259a19cb072f1874ef7c382092156469be94b5caecad97bc995bd3df1bc31b25fd58e1');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2940, 27986, 'Tegaserod', 'Food reduces the bioavailability of tegaserod by 40 to 65% and the maximum plasma concentration (Cmax) by 20 to 40%.', 'food', 'Moderate', '', 'DDInter', 0, X'789c0b494d4f2c4e2dca4f5128cec82fcd4951484a552849cc4ecd0332d2f28b5215725313738af50023fd0e5b', NULL, X'789c1dcb510ac2301045d1adbc9f82fd9122ad1b10dcc74b32ea409291642a76f7d67edf7bee66094dd21aa5c35f82a0c60f35336856df600fb83cd9a5ed63d8304f70c37519c09a0e51f8d5b216bc337b21a2d528d51b5dade274dbf3f8879703ced370fe01756827a7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2941, 29867, 'Tegaserod', 'Food reduces the bioavailability of tegaserod by 40 to 65% and the maximum plasma concentration (Cmax) by 20 to 40%.', 'food', 'Moderate', '', 'DDInter', 0, X'789c0b494d4f2c4e2dca4f5128cec82fcd4951484a552849cc4ecd0332d2f28b5215725313738af50023fd0e5b', NULL, X'789c1dcb510ac2301045d1adbc9f82fd9122ad1b10dcc74b32ea409291642a76f7d67edf7bee66094dd21aa5c35f82a0c60f35336856df600fb83cd9a5ed63d8304f70c37519c09a0e51f8d5b216bc337b21a2d528d51b5dade274dbf3f8879703ced370fe01756827a7');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2943, 3617, 'Belladonna', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2945, 2472, 'Telmisartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2946, 15252, 'Telmisartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2947, 16225, 'Telmisartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2948, 21692, 'Telmisartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2949, 21693, 'Telmisartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2950, 22693, 'Telmisartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2951, 22694, 'Telmisartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2952, 29869, 'Telmisartan', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2953, 2472, 'Telmisartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c158c310ec2400c04bfb22548813f404741c30f9c64c959b99c4fb62394df03e54833f3b4992ec94bdaa5e852302b53fc80b69495b037baa544e8be0d60744e2ab51e08a989d8c748cd3d190336f957935382c842b8c6fa1f94a3d357a9dc547e06c236a24b2a5b063ec5204eeca16d81b4452dd97e80c703ce893dcd31569b567ae0747bdde37cfd02e87643e9');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2954, 15252, 'Telmisartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c158c310ec2400c04bfb22548813f404741c30f9c64c959b99c4fb62394df03e54833f3b4992ec94bdaa5e852302b53fc80b69495b037baa544e8be0d60744e2ab51e08a989d8c748cd3d190336f957935382c842b8c6fa1f94a3d357a9dc547e06c236a24b2a5b063ec5204eeca16d81b4452dd97e80c703ce893dcd31569b567ae0747bdde37cfd02e87643e9');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2955, 16225, 'Telmisartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c158c310ec2400c04bfb22548813f404741c30f9c64c959b99c4fb62394df03e54833f3b4992ec94bdaa5e852302b53fc80b69495b037baa544e8be0d60744e2ab51e08a989d8c748cd3d190336f957935382c842b8c6fa1f94a3d357a9dc547e06c236a24b2a5b063ec5204eeca16d81b4452dd97e80c703ce893dcd31569b567ae0747bdde37cfd02e87643e9');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2956, 21692, 'Telmisartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c158c310ec2400c04bfb22548813f404741c30f9c64c959b99c4fb62394df03e54833f3b4992ec94bdaa5e852302b53fc80b69495b037baa544e8be0d60744e2ab51e08a989d8c748cd3d190336f957935382c842b8c6fa1f94a3d357a9dc547e06c236a24b2a5b063ec5204eeca16d81b4452dd97e80c703ce893dcd31569b567ae0747bdde37cfd02e87643e9');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2957, 21693, 'Telmisartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c158c310ec2400c04bfb22548813f404741c30f9c64c959b99c4fb62394df03e54833f3b4992ec94bdaa5e852302b53fc80b69495b037baa544e8be0d60744e2ab51e08a989d8c748cd3d190336f957935382c842b8c6fa1f94a3d357a9dc547e06c236a24b2a5b063ec5204eeca16d81b4452dd97e80c703ce893dcd31569b567ae0747bdde37cfd02e87643e9');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2958, 22693, 'Telmisartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c158c310ec2400c04bfb22548813f404741c30f9c64c959b99c4fb62394df03e54833f3b4992ec94bdaa5e852302b53fc80b69495b037baa544e8be0d60744e2ab51e08a989d8c748cd3d190336f957935382c842b8c6fa1f94a3d357a9dc547e06c236a24b2a5b063ec5204eeca16d81b4452dd97e80c703ce893dcd31569b567ae0747bdde37cfd02e87643e9');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2959, 22694, 'Telmisartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c158c310ec2400c04bfb22548813f404741c30f9c64c959b99c4fb62394df03e54833f3b4992ec94bdaa5e852302b53fc80b69495b037baa544e8be0d60744e2ab51e08a989d8c748cd3d190336f957935382c842b8c6fa1f94a3d357a9dc547e06c236a24b2a5b063ec5204eeca16d81b4452dd97e80c703ce893dcd31569b567ae0747bdde37cfd02e87643e9');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2960, 29869, 'Telmisartan', 'Moderate-to-high dietary intake of potassium, especially salt substitutes, may increase the risk of hyperkalemia in some patients who are using angiotensin II receptor blockers (ARBs).', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c158c310ec2400c04bfb22548813f404741c30f9c64c959b99c4fb62394df03e54833f3b4992ec94bdaa5e852302b53fc80b69495b037baa544e8be0d60744e2ab51e08a989d8c748cd3d190336f957935382c842b8c6fa1f94a3d357a9dc547e06c236a24b2a5b063ec5204eeca16d81b4452dd97e80c703ce893dcd31569b567ae0747bdde37cfd02e87643e9');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2964, 28355, 'Temsirolimus', 'Coadministration of temsirolimus with grapefruit juice may increase the plasma concentrations of sirolimus, a major active metabolite of temsirolimus and known substrate of CYP450 3A4.  The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism by certain compounds present in grapefruits.', 'grapefruit juice', 'Moderate', '', 'DDInter', 0, X'789c4dc7cb0d42310c04c056b6026aa105f3b22146491cf903a27baecc6dee92ca9d81744ab2e1a339905ca16e5357056258cd86e3ec7479cc2fe46dda9083b86c47ad936a1bd6f17439ec5e9a30ffdfabf4e2ed0713ac29ef', NULL, X'789c658f514e42410c45b772178084445c8061037ef8e367df4cf11598f665da91b07b0b5130f1bbb7e7deb333aa4d543c3a8598c2f6086e2edd4ed286e32c31e3b3d3c2fb3e24701852188d2e102d9dc91931339613792314d3c2fac3f22bec4e5a81f2ed601d5442be92c14153de82ff9592561cd5ce0a1fd36dda2db3fb78dbbe6cf0fcba5d03efd7d66e8b39d7649599d2a2413c87cd32c9afcde3e9a9719544d57b75e6a70b0af720d11cdf161b5a3db9eca991a43feabefe062d6d6e7c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2965, 6681, 'Terazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2966, 6682, 'Terazosin', 'The concurrent use of ethanol and alpha-1 adrenergic blockers may cause increased hypotensive effects.  Patients with aldehyde dehydrogenase deficiencies (primarily Asians) may be at a higher risk of this interaction.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c458f5d72c3300884afb28fed4bee901bf40a58c21153021e81ecf1edab78daf489e167bf5dbe28852d03477354de597d0308ab8e68620f74a692e2065a933b381b992be68ae39a7f885529941c53b679842cca20addccecab84af7071bc5ab5ba54cc3727e229a0fad58e671dd25b8221db4bbd4b78b77a83c25918da54fd3a46fbe0177556c7fc9ff3907759b185a7c5c92df38a292277c9db86c1e398505eddc3cd9e2f5c221d950dccae87d22dff623f8f603df296bff', NULL, X'789c1d4e5b6e02410cbb8a3fcb47917a046ec0472f1066bc9b8825b34a42abbd3d031f9665c9af5f25daf0f68ca0179e498c052c151f1bc43b64db55be7f207d3a18ab35dcb6d1ee8cc4430e347987cc5b50921d7aeca3e8697f049785adf20c5ca56c0e24fead747676ead1890fc558e9333bd5626dda26125f7bd843c2b6039734f13c7de66e8414046aab321096f7f7e352cb79a218d2ca869f5f19d24fdd');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2967, 2546, 'Benazepril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2968, 2548, 'Benazepril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2969, 28765, 'Benazepril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2970, 28766, 'Benazepril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2971, 28767, 'Benazepril', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2972, 2546, 'Benazepril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2973, 2548, 'Benazepril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2974, 28765, 'Benazepril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2975, 28766, 'Benazepril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2976, 28767, 'Benazepril', 'Moderate-to-high dietary intake of potassium can cause hyperkalemia in some patients who are using angiotensin converting enzyme (ACE) inhibitors.  In some cases, affected patients were using a potassium-rich salt substitute.  ACE inhibitors can promote hyperkalemia through inhibition of the renin-aldosterone-angiotensin (RAA) system.', 'Food High in Potassium', 'Moderate', '', 'DDInter', 0, X'789c4d8db111c23010045bb90adc03c31090d1c2db7aac1f64bd477f32e3eeb12121ba646ff74e58a0e9e4cba2356902b310abd0b432f0ce0e690acacbea8ccbf506abd946a3b7c0a890b4599cb783dbdc12164fda845a76649b33bcfd76754a84f505c994d2f643745875001ed268532fd220e4d135af88ecbda433b18a7dfdccfa6799bc9e28fc899042441f83c64e8de103faec4f3e', NULL, X'789c55904d6ec3400885afc23291eadcc1aabae8a29bde80d8cf1e141b2c605ab9a7efa48a1477c182bf8ff7f8b011ce892ead2b32171a05c9be9368f20d64136d961c2175a581b5450d50d937f88d17acc26d94c256d0c629d00cfa2e46eca01aa233b1ce62096d090da65ff0bc97a13f7b5b3af5af6fe786287295348f0bd1fb833770205e88a70943623cf0f1843fe5752e43a1e02529ea3552b2261aae1d38f0ff4c6c6e6b93f4df4616b7da3ef09815d3bbfb2c20878a76bc8c1609374577f474faecfb33c5de7aebe517cd4d7c07');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2977, 151, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2978, 11330, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2979, 11336, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2980, 11338, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2981, 11339, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2982, 11340, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2983, 27721, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2984, 28086, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2985, 28087, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2986, 28088, 'Tetracycline', 'Administration with food, particularly dairy products, significantly reduces tetracycline absorption.  The calcium content of these foods forms nonabsorbable chelates with tetracycline.', 'dairy products', 'Moderate', '', 'DDInter', 0, X'789c1dcad109c0200c45d155de049da60ba4faa4821a4822a5db37f4f79e7b324cca5b465f84dfba47c545489d7d750f1a2b3429c5129a1aa18678f44f0e69396152861f1f728f1cc8', NULL, X'789c4d8ed10dc340084357f1005177e80e5d8070a48774810888aa6cdf6bbefae30f5b7ef6b3ed6a9a1554ea868f56c7e6de161c14a57c0e8a71a191c68523bc9d5cb920f56dba2993d54c43a62d8992c9e18b879a80d6f4387ed407f0ea02a6c17aee60b7122bf886ea9272efe5d4d813e67617575ac7ac741954937cfffac73fbeaa73465d');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2989, 14611, 'Teriflunomide', 'The recent, concomitant, or subsequent use (without the recommended leflunomide washout period or procedure) of other agents known to induce hepatotoxicity may potentiate the risk of liver injury associated with leflunomide.  The risk is thought to extend to teriflunomide, its principal active metabolite, because recommended dosages of both result in a similar range of plasma concentrations of teriflunomide.  Elevated liver transaminases, hepatitis, jaundice/cholestasis, hepatic failure, and acute hepatic necrosis have been reported with the use of leflunomide.  Liver enzyme elevations were generally mild (2 times the upper limit of normal or less) and resolved while continuing treatment.  Marked elevations (greater than 3-fold ULN) occurred infrequently and reversed with dose reduction or discontinuation of treatment in most cases.', 'alcohol', 'Major', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2991, 23204, 'Thalidomide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2992, 28097, 'Thalidomide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2993, 28098, 'Thalidomide', 'Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.  Use in combination may result in additive central nervous system depression and/or impairment of judgment, thinking, and psychomotor skills.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c1d8ecb0dc3300c4357e100fdcc50f4de4bd101545b49d4d896612901b27deddc04f03d528f1474d1844c07aa3a171772866966e8045f1875a1962968d25902789a38b88df0f97a5f29b8ec0c9abb6937e0630c29089abf52c845cb59ddd8b6e423a118e55442371a25146ebb6e063bcc392372edb00d914abc6b83e44ad272c7c7e86f8bf3b82ffd3729ab94f93240543bc2a259bd1bb64a4a76fb0301fd51b0');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2994, 684, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2995, 8210, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2996, 11348, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2997, 11349, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2998, 11354, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (2999, 11909, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3000, 12208, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3001, 12209, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3002, 14071, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3003, 16323, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3004, 25546, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3005, 25547, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3006, 28102, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3007, 28105, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3008, 28106, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3009, 28107, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3010, 28108, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3011, 28745, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3012, 29717, 'Theophylline', 'Coadministration with caffeine may increase the serum concentrations of theophylline.  The proposed mechanism involves competitive inhibition of theophylline metabolism via CYP450 1A2, as well as metabolic conversion of caffeine to theophylline in vivo and saturation of theophylline metabolism at higher serum concentrations.', 'coffee', 'Moderate', '', 'DDInter', 0, X'789c55cf414e43310c04d0abcc010a126b0ec23a6de6f75b4aecc8712ab83d4e61019b2872c6cfcec74945a95d5466d05911865142a831e1bc511ea277dc4c4374d99ac8177a69d0152e21a6b8605a27f839e83f5dd63b35adb3441e44ac2b7190755bf3b4d52ab2229bf23522e71ee6c8746399813764c6339255a224f55b2947763cc96a93b063df6d9c5fad892638719707f51d5e86d417e7f6b8f1be5ad9db4e942487f3c85f5c1b2f4ffe9fd2f8609b7ff6eca612b9497dfd06af6c711c', NULL, X'789c7d90418a02410c45aff20f20328a1e60f0022edccc3256a7ad4055a5a9c4126f6fb5f40c2883ab40f2fffb490e4a439622e6955cb4e0261e11681c590a23d31d5242653286478671bd66042d81cb6231e838cf748af794ba6b0d9cba74aa3aa9f180cc21528fc81dd53435b60ec813bbb834eecd28677986bf81bad3e9ac69b636211c7e8ebbfd1736dfdb15c870e394e6faab0af35e8dab2da8bf2b5c5fb1523aae29a80c30f2eb72fa87747244b944aeff3e60fd001dff7a0f');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3013, 11385, 'Thioridazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c05c1810d80300804c0557e02677105142224049a429be8f4de9dd426d185d25cceb804c4db4a189da09dc620bf53d3c16b5a3c182a91ad469f85a055268df7f801f6f21ba1', NULL, X'789c5d8ec10d02310c045bd902d0f580eecf870aacc4108b8b1dc50ee8a89e9c9078f05ecdccaea669f4ce1a18ceb01b380aa96d20cd6885d5a208bd45d9516947671f5b401494b3843c19ebe58acc6d2e2ea65fd0f754ac5a5887d446d2eb4c2cc079733bfd1a877072499a040523ef1ea6926685524c991fa146219376bc8a813a23e8217aff7bb77c0050c64c48');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3014, 28140, 'Thioridazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c05c1810d80300804c0557e02677105142224049a429be8f4de9dd426d185d25cceb804c4db4a189da09dc620bf53d3c16b5a3c182a91ad469f85a055268df7f801f6f21ba1', NULL, X'789c5d8ec10d02310c045bd902d0f580eecf870aacc4108b8b1dc50ee8a89e9c9078f05ecdccaea669f4ce1a18ceb01b380aa96d20cd6885d5a208bd45d9516947671f5b401494b3843c19ebe58acc6d2e2ea65fd0f754ac5a5887d446d2eb4c2cc079733bfd1a877072499a040523ef1ea6926685524c991fa146219376bc8a813a23e8217aff7bb77c0050c64c48');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3015, 28141, 'Thioridazine', 'Concurrent use of ethanol and phenothiazines may result in additive CNS depression and psychomotor impairment.  Also, ethanol may precipitate dystonic reactions in patients who are taking phenothiazines.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c05c1810d80300804c0557e02677105142224049a429be8f4de9dd426d185d25cceb804c4db4a189da09dc620bf53d3c16b5a3c182a91ad469f85a055268df7f801f6f21ba1', NULL, X'789c5d8ec10d02310c045bd902d0f580eecf870aacc4108b8b1dc50ee8a89e9c9078f05ecdccaea669f4ce1a18ceb01b380aa96d20cd6885d5a208bd45d9516947671f5b401494b3843c19ebe58acc6d2e2ea65fd0f754ac5a5887d446d2eb4c2cc079733bfd1a877072499a040523ef1ea6926685524c991fa146219376bc8a813a23e8217aff7bb77c0050c64c48');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3017, 718, 'Thiopental', 'Concurrent acute use of barbiturates and ethanol may result in additive CNS effects,  including impaired coordination, sedation, and death.  Tolerance of these agents may occur with chronic use.  The mechanism is related to inhibition of microsomal enzymes acutely and induction of hepatic microsomal enzymes chronically.', 'alcohol', 'Major', '', 'DDInter', 0, X'789c0dc8d10d80300805c055de044ee3020fc140522169a9f3eb7ddee986ab1e89644725ea86b5336b80a9104e89de936d0bcb6b8fff0c7c2bd4f4f800d92f1710', NULL, X'789c6dcf416e03210c05d0abfc0344b944f6ddb417708c2758023b02d36a7afa7a46c9ae3b04d8fffd9b1baf31c402c42b046b0a7cc39dc65d630d0a99202b90a864ded069c790b95a400d548a867e0b6e1f9f906d138e7941be705b45ed01ed4fd22105ec3ef28642dd2e98525ea76377118a7a05bebcc920e353105592428fa4cd33d539a5f8d1a8e03adc940fec3156055d387d3a3b74a6afa5bb203c2555b348461d3bbbf2f0e99d1ac47ef77e743b5ab7fd74a895c5efbf559e49e4ff665ef1d4da7efd03fb847673');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3018, 28125, 'Thiopental', 'Concurrent acute use of barbiturates and ethanol may result in additive CNS effects,  including impaired coordination, sedation, and death.  Tolerance of these agents may occur with chronic use.  The mechanism is related to inhibition of microsomal enzymes acutely and induction of hepatic microsomal enzymes chronically.', 'alcohol', 'Major', '', 'DDInter', 0, X'789c0dc8d10d80300805c055de044ee3020fc140522169a9f3eb7ddee986ab1e89644725ea86b5336b80a9104e89de936d0bcb6b8fff0c7c2bd4f4f800d92f1710', NULL, X'789c6dcf416e03210c05d0abfc0344b944f6ddb417708c2758023b02d36a7afa7a46c9ae3b04d8fffd9b1baf31c402c42b046b0a7cc39dc65d630d0a99202b90a864ded069c790b95a400d548a867e0b6e1f9f906d138e7941be705b45ed01ed4fd22105ec3ef28642dd2e98525ea76377118a7a05bebcc920e353105592428fa4cd33d539a5f8d1a8e03adc940fec3156055d387d3a3b74a6afa5bb203c2555b348461d3bbbf2f0e99d1ac47ef77e743b5ab7fd74a895c5efbf559e49e4ff665ef1d4da7efd03fb847673');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3019, 28127, 'Thiopental', 'Concurrent acute use of barbiturates and ethanol may result in additive CNS effects,  including impaired coordination, sedation, and death.  Tolerance of these agents may occur with chronic use.  The mechanism is related to inhibition of microsomal enzymes acutely and induction of hepatic microsomal enzymes chronically.', 'alcohol', 'Major', '', 'DDInter', 0, X'789c0dc8d10d80300805c055de044ee3020fc140522169a9f3eb7ddee986ab1e89644725ea86b5336b80a9104e89de936d0bcb6b8fff0c7c2bd4f4f800d92f1710', NULL, X'789c6dcf416e03210c05d0abfc0344b944f6ddb417708c2758023b02d36a7afa7a46c9ae3b04d8fffd9b1baf31c402c42b046b0a7cc39dc65d630d0a99202b90a864ded069c790b95a400d548a867e0b6e1f9f906d138e7941be705b45ed01ed4fd22105ec3ef28642dd2e98525ea76377118a7a05bebcc920e353105592428fa4cd33d539a5f8d1a8e03adc940fec3156055d387d3a3b74a6afa5bb203c2555b348461d3bbbf2f0e99d1ac47ef77e743b5ab7fd74a895c5efbf559e49e4ff665ef1d4da7efd03fb847673');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3020, 28128, 'Thiopental', 'Concurrent acute use of barbiturates and ethanol may result in additive CNS effects,  including impaired coordination, sedation, and death.  Tolerance of these agents may occur with chronic use.  The mechanism is related to inhibition of microsomal enzymes acutely and induction of hepatic microsomal enzymes chronically.', 'alcohol', 'Major', '', 'DDInter', 0, X'789c0dc8d10d80300805c055de044ee3020fc140522169a9f3eb7ddee986ab1e89644725ea86b5336b80a9104e89de936d0bcb6b8fff0c7c2bd4f4f800d92f1710', NULL, X'789c6dcf416e03210c05d0abfc0344b944f6ddb417708c2758023b02d36a7afa7a46c9ae3b04d8fffd9b1baf31c402c42b046b0a7cc39dc65d630d0a99202b90a864ded069c790b95a400d548a867e0b6e1f9f906d138e7941be705b45ed01ed4fd22105ec3ef28642dd2e98525ea76377118a7a05bebcc920e353105592428fa4cd33d539a5f8d1a8e03adc940fec3156055d387d3a3b74a6afa5bb203c2555b348461d3bbbf2f0e99d1ac47ef77e743b5ab7fd74a895c5efbf559e49e4ff665ef1d4da7efd03fb847673');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3021, 28129, 'Thiopental', 'Concurrent acute use of barbiturates and ethanol may result in additive CNS effects,  including impaired coordination, sedation, and death.  Tolerance of these agents may occur with chronic use.  The mechanism is related to inhibition of microsomal enzymes acutely and induction of hepatic microsomal enzymes chronically.', 'alcohol', 'Major', '', 'DDInter', 0, X'789c0dc8d10d80300805c055de044ee3020fc140522169a9f3eb7ddee986ab1e89644725ea86b5336b80a9104e89de936d0bcb6b8fff0c7c2bd4f4f800d92f1710', NULL, X'789c6dcf416e03210c05d0abfc0344b944f6ddb417708c2758023b02d36a7afa7a46c9ae3b04d8fffd9b1baf31c402c42b046b0a7cc39dc65d630d0a99202b90a864ded069c790b95a400d548a867e0b6e1f9f906d138e7941be705b45ed01ed4fd22105ec3ef28642dd2e98525ea76377118a7a05bebcc920e353105592428fa4cd33d539a5f8d1a8e03adc940fec3156055d387d3a3b74a6afa5bb203c2555b348461d3bbbf2f0e99d1ac47ef77e743b5ab7fd74a895c5efbf559e49e4ff665ef1d4da7efd03fb847673');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3022, 28130, 'Thiopental', 'Concurrent acute use of barbiturates and ethanol may result in additive CNS effects,  including impaired coordination, sedation, and death.  Tolerance of these agents may occur with chronic use.  The mechanism is related to inhibition of microsomal enzymes acutely and induction of hepatic microsomal enzymes chronically.', 'alcohol', 'Major', '', 'DDInter', 0, X'789c0dc8d10d80300805c055de044ee3020fc140522169a9f3eb7ddee986ab1e89644725ea86b5336b80a9104e89de936d0bcb6b8fff0c7c2bd4f4f800d92f1710', NULL, X'789c6dcf416e03210c05d0abfc0344b944f6ddb417708c2758023b02d36a7afa7a46c9ae3b04d8fffd9b1baf31c402c42b046b0a7cc39dc65d630d0a99202b90a864ded069c790b95a400d548a867e0b6e1f9f906d138e7941be705b45ed01ed4fd22105ec3ef28642dd2e98525ea76377118a7a05bebcc920e353105592428fa4cd33d539a5f8d1a8e03adc940fec3156055d387d3a3b74a6afa5bb203c2555b348461d3bbbf2f0e99d1ac47ef77e743b5ab7fd74a895c5efbf559e49e4ff665ef1d4da7efd03fb847673');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3025, 4704, 'Tinidazole', 'Use of alcohol or products containing alcohol during nitroimidazole therapy may result in a disulfiram-like reaction in some patients.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c3dc9c10dc3300c04c156ae01a79b144048747c88440a14f5b0ab8ffdc96f17f39e0adf21adf8e10d1e18e175959c286e2934dae7cf75c5b3c60c676795cb9b220f0d1927ba9c089dab25681054debd33a46f8d5fbd4d4ad2edd1e95d3124a996f3f50358b3328c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3026, 25437, 'Tinidazole', 'Use of alcohol or products containing alcohol during nitroimidazole therapy may result in a disulfiram-like reaction in some patients.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c3dc9c10dc3300c04c156ae01a79b144048747c88440a14f5b0ab8ffdc96f17f39e0adf21adf8e10d1e18e175959c286e2934dae7cf75c5b3c60c676795cb9b220f0d1927ba9c089dab25681054debd33a46f8d5fbd4d4ad2edd1e95d3124a996f3f50358b3328c');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3028, 24890, 'Tiludronic acid', 'Food significantly decreases the bioavailability of tiludronate.  The manufacturer reports up to a 90% decrease in bioavailability when administered with or 2 hours after a standard breakfast.  Clinical efficacy, however, was demonstrated when tiludronate was taken 2 hours before or after meals.', 'food', 'Moderate', '', 'DDInter', 0, X'789c3d8cb10dc3300c0457f90952a408328817a0430a2620eb039282d78fdca43ddcdde67d6a704819f2e0ec8add207afaf02c0b535c5e075e28e20dcef1b1041bbe5d7ce05a5d400add240b4fac45e45a348681f127d26eb191faf8017a3a2911', NULL, X'789c658f414e03410c04bfd2176e5184b87146e2057cc03be361adcc8e23db93d5fe1e870884c4b5d5ae6abfab56b87c0e695268443f50b91893b32356c6224a37924e8b748903da10d267351d147c063eb2b4d1988d4a4c6383f1552d1cf38a50105e9f9f7e9990f18fb8af3c407593211e6c5cb14bac50c30b569de6a09679923c6854b28a256197461ee97feb7958a883dbfd85729cf26ae71bdb093b79aa371d1e966bebc3f567ff7723e892e98f6ce1a6c677fd43bb31753f7f015ac46c86');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3030, 2880, 'Benzatropine', 'Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous.  In addition, the potential for abuse may be increased with the combination.  The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c358ddb11c2300c045bb90ad2031dd082b09558836283252793ee51207c6846afdbbd696aa529acb4a1190b57eea47ae0c1a0ad49e68c3cbad4055ee2f43ab08b175075491194f85f248122e93601777239db3f3138a98d6aac41f2f6838292cb26f169e8fc1ef215ac9123052977af6c8611123dbd079eb5ed285131195f3ad03c73f273b74e1f290b4be3', NULL, X'789c2d905172c5200845b77217d079fbe87fbb00a2189951c90849275d7d31af7f287038f06d0c2da0e192aa36193c7749a09d871b7ec42ba8258d143add986c6773c8809da548922883f48364f6152e947b44a251a220836b748dcc1379ca25638f61197af0245faf4ea9aeb137ba4e46a55f9a594f7b019f0394b32cd807bc320e7dd8d4507482b633ec97d6c6a1942693717e4bafeaa47d9341ab3d605ff1d339551a627d89caf070488faa18863ad89cb6265603b39dfeb0655cda2efe378920f31167b03819b8144e71a7203c03436e865c6c73c506b0db9cfbeb0f3bec8453');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3031, 9104, 'Timolol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3032, 11431, 'Timolol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c3d90eb6d043108845ba180d335910622a502d6b06b24afb10c5ec5577df09e2e3f79cc37035f385cb402568254d4184eade2daa51eb06b07e28b8bb693ab83ee906753e76a4b230648971813d0b80549914ea962def1c686c23307158f00d813e047cfa886e7b0706183ce49cfc013e0a5420b832569d60252a1056729d71acbb5a6179a929418acd5ea1299b8dfa12e06eae3583edf1fa1651d8560e3ffb0ae6f2be8623763eba37999b0773d01c1c46f765c1faee3dcd6ed4da3fdf95410aabaec735d271d5a9e2649307e721f3c817f2353044891485e2fa96cf68022478e3112d3bb61b3266dfc08aff888399ad82ac031e599b093e0f30fc2489eac', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3033, 11433, 'Timolol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3034, 11435, 'Timolol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3035, 16964, 'Timolol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'789c55504b72c33008bd0acb76c6f125b26e373d019148c454161a81d3e8f645b217ed8e81f7789f0f2c1daaf690c41235acb41b07c012e1faf975c160fc24c007155378a3f5b12e7e7cb1e4ee385d4029e2c0f8987a2d726cb11847aa8d547d3c17a7cc044865e1380e394892bcc0b66bc8048d32be06e71de895f8c636fe8a51d1e184ee770ae32169a5c0987387b8372e0fe0c2c6ee450ac81d8e347d2689a2ced480799e5780ab60dc9ca0d60ec60f5b9a265d8cdaa9a6933d8bf967e2a8637145a8d83cd09eb1c1135522bb84b48388b926bcdcb2846f6a0edfb07b3cddb30d26c6c8f62712b80bc74a8459dbdee8506f96440d9575fd05d6c1a145');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3036, 27915, 'Timolol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3037, 28196, 'Timolol', 'Many psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially during initiation of therapy and dose escalation.  Coadministration with antihypertensives and other hypotensive agents, in particular vasodilators and alpha-blockers, may result in additive effects on blood pressure and orthostasis.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3038, 28179, 'Ticlopidine', 'The bioavailability and gastrointestinal tolerance of ticlopidine is enhanced by food.', 'food', 'Moderate', '', 'DDInter', 0, X'789c05c18b0980500c03c0553281b3b842b50183ef070d8adb7bb787c5e1428f0f0711f9a898f084e326acb3cda5d4205ef94267b4da7e395f144f', NULL, X'789c15c9d10980300c05c055de044ee302a949ed8390481b846e2fdeef9dc3d098f20a5d1a9db521a1b865d54c46d92a86382adda6c465c88ee2e5f95019062e588c7f146da367eaf1019c0b207e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3039, 28180, 'Ticlopidine', 'The bioavailability and gastrointestinal tolerance of ticlopidine is enhanced by food.', 'food', 'Moderate', '', 'DDInter', 0, X'789c05c18b0980500c03c0553281b3b842b50183ef070d8adb7bb787c5e1428f0f0711f9a898f084e326acb3cda5d4205ef94267b4da7e395f144f', NULL, X'789c15c9d10980300c05c055de044ee302a949ed8390481b846e2fdeef9dc3d098f20a5d1a9db521a1b865d54c46d92a86382adda6c465c88ee2e5f95019062e588c7f146da367eaf1019c0b207e');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3040, 2094, 'Tizanidine', 'The sedative effect of tizanidine may be potentiated by concomitant use of other agents with central nervous system (CNS) depressant effects.  In addition, tizanidine and many of these agents (e.g., alcohol, anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, muscle relaxants) also can exhibit hypotensive effects, which may be additive during coadministration and may increase the risk of symptomatic hypotension and orthostasis, particularly during initiation of therapy or dose escalation.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3041, 10094, 'Tizanidine', 'The sedative effect of tizanidine may be potentiated by concomitant use of other agents with central nervous system (CNS) depressant effects.  In addition, tizanidine and many of these agents (e.g., alcohol, anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, muscle relaxants) also can exhibit hypotensive effects, which may be additive during coadministration and may increase the risk of symptomatic hypotension and orthostasis, particularly during initiation of therapy or dose escalation.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3042, 10120, 'Tizanidine', 'The sedative effect of tizanidine may be potentiated by concomitant use of other agents with central nervous system (CNS) depressant effects.  In addition, tizanidine and many of these agents (e.g., alcohol, anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, muscle relaxants) also can exhibit hypotensive effects, which may be additive during coadministration and may increase the risk of symptomatic hypotension and orthostasis, particularly during initiation of therapy or dose escalation.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'789c5d525baedc3008dd0a0b18ddaea1baff55a5ae80d8648c6a1b17f04c33ab2f4eaee6a31f966272e03cf0274e67e9c006981f6c94017b86264a7057cc132b64310267573ca10d0fd808700c95a18c4ef02cd403f1c2ce993bad69738d7ab217102fa4607333c79ec8c00b3a24ec7102059f3f7e41a6a164b6c607fd375128c710a7be4a3718a8ce6956d47a0077a09a697d062ed3c6953d54e480395377fb00f8deb680bbe8f1ae821599352fed496637aad1e202f810ce50f0859a65460ec9f9c1d163a0f467b272bf47471b95c26a8b5191095652ef21f92bae600a8c68d8bf529addb986553ae07797279438710bbf783fd5e0be53f2556bb773c85b8ab22d4adc740e0f97bb4a030463f7550f26a534db1663604894832f2cfffccf6792507a31b0c2288771e2489df74b16fd1da4d1910832bf5ebcdcdca0f2bdc46fcc94af821d3dc9a05bf07a91d8a1b1ad4bf4a7b5b2c7b5413aed7c2d97bb93ee146fe87c0197822eda5672ef783ffe0144d2eebf', NULL, X'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');
INSERT OR REPLACE INTO food_interactions (id, med_id, trade_name, interaction, ingredient, severity, reference_text, source, created_at, management_text_blob, mechanism_text_blob, interaction_blob) VALUES (3043, 10536, 'Tizanidine', 'The sedative effect of tizanidine may be potentiated by concomitant use of other agents with central nervous system (CNS) depressant effects.  In addition, tizanidine and many of these agents (e.g., alcohol, anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, muscle relaxants) also can exhibit hypotensive effects, which may be additive during coadministration and may increase the risk of symptomatic hypotension and orthostasis, particularly during initiation of therapy or dose escalation.', 'alcohol', 'Moderate', '', 'DDInter', 0, X'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', NULL, X'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');